Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial
Sadanori Okada(Hyogo Medical University), Masanori Kamura, Hirofumi Soejima(Kumamoto Health Science University), Hisao Ogawa(Kumamoto University Hospital), Makoto Ikemura, Kazuo Gotō, Yoshiko Shioya, Shinya Yumoto, Izuru Masuda(Takeda (Japan)), Eiitiro Tanaka, Hideaki Jinnouchi, Masako Waki(Shizuoka City Hospital), Masafumi Nakayama(Kumamoto University), Kenichi Ashihara, Satoshi Tanazawa, Isao Yasuda, Yoshihiro Kimura, Kenichi Doijiri, Yoshihiko Saito(National Archives and Records Administration), Genshi Egusa(National Institutes of Health), Osamu Haraguchi, Seigo Sugiyama(Diabetes Care Center), Chieko Imamoto, Takeshi Morimoto(Hyogo Medical University), Norifumi Kondo, Ken Iwai(Kumamoto University), Atsushi Hasegawa, Michio Shimabukuro(Fukushima Medical University), Yutaka Mitsudo, Kazuhiko Yamada, Kazunobu Akahoshi, Chisa Matsumoto(Brigham and Women's Hospital), Kimiaki Miwa, Toshiya Atsumi(Feinstein Institute for Medical Research), Naofumi Doi(Nara Medical University), Haruo Araki, Yosuke Shioya, Yoshikuni Haraguchi, Masashi Horimoto, Yoichi Hanaoka, Yoshihisa Iseri, Shinya Okamoto, Ryo Fukami, Osamu Doi(Shizuoka General Hospital), Tsuneo Ikeda, Mio Sakuma(Hyogo Medical University), Yutaka Horio, Kenji Misumi
Cited by 24
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821